Beruflich Dokumente
Kultur Dokumente
OF INDIA
II
THE
AYURVEDIC
PHARMACOPOEIA
OF
INDIA
PART - I
VOLUME - VI
First Edition
GOVERNMENT OF INDIA
MINISTRY OF HEALTH AND FAMILY WELFARE
DEPARTMENT OF AYURVEDA, YOGA & NATUROPATHY, UNANI,
SIDDHA AND HOMOEOPATHY,
NEW DELHI
2008
III
Price
Inland
Foreign
ISBN
978-81-905952-1-6
Published by
On Behalf of
GOVERNMENT OF INDIA
DEPARTMENT OF AYURVEDA, YOGANATUROPATHY, UNANI, SIDDHA AND
HOMOEOPATHY (AYUSH), INDIAN RED
CROSS SOCIETY BUILDING, SANSAD
MARG, NEW DELHI
WEBSITE
www.indianmedicine.nic.in
Printed at
IV
Foreword
VI
CONTENTS
PAGE
LEGAL NOTICES
.
GENERAL NOTICES .
PREFACE
.
ACKNOWLEDGEMENT
INTRODUCTION
.
CONTRIBUTING LABORATORIES & INSTITUTIONS
XIII
XIV
XIX
XXI
XXII
XXX
MONOGRAPHS
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
dr (Lf.)
mragandhi-guggulu (Lf.)
Araya-sraa (Tuber )
rroa (Rz.)
Asthikhal (Aerial Part)
Bhtake (Fr.)
Bhtake (Rz.)
Bjapatr (Wh. Pl.)
Bimb (Lf.)
Bimb (St.)
Bhat Dugdhik (Wh.Pl.)
Bhat(Wh.Pl.)
Caaka (Wh. Pl.)
Druharidr (Fr.)
Dhava (Fr.)
Dhava (St. Bk.)
Dvpntara Damanaka (Wh.Pl.)
Dvpntara atvar (Rt.)
Elavlukam (Rt.)
Elavlukam (St. Bk.)
Eraakarka (Fr.)
Eraakarka (Rt.)
Gandhaiph (Wh.Pl.)
Grmachatraka (Wh. Pl.)
Gokura (Wh. Pl.)
Granthimla (Rz.)
Guladud (Lf.)
Haritamajar (Wh.Pl.)
Hastiu (Wh. Pl.)
Indvara (Rz.)
Jalakumbh (Wh.Pl.)
Jvant (Rt.)
Kaakgulma (Aerial Part)
Karaphs (Rt.)
Kaugulma (Wh.Pl.)
Kearja (Wh. Pl.)
Ketak (Stilt Rt.)
Kamr (Lf.)
Kumrvetra (Rz.)
VII
1
3
5
7
9
12
14
16
19
21
23
26
29
32
34
36
38
41
43
45
47
49
51
54
56
59
61
63
66
68
70
73
75
78
80
83
86
88
90
40.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
71.
72.
73.
74.
75.
76.
77.
78.
79.
Kusumbha (Fr.)
Kusumbha (Lf.)
Kusumbha (Fl.)
Laghu Haritamajar (Rt.)
Laghupatra-varbh (Wh.Pl.)
Lohitanirysa (Exd.)
Mdhav (Fl.)
Matsyapatrik (Wh.Pl.)
Med (Rz.)
Ndhingu (Exd.)
Nh (Wh.Pl.)
Nikocaka (Kernel)
Panasa (Rt. Bk.)
Papaa (Rt.)
Parayavn (Lf.)
Patra snuh (Latex)
Pia Tagara (Rz.)
Pta-kacanra (Fl.)
Rakta Citraka (Rt.)
Rohtaka (St.Bk.)
la (Ht. Wd.)
lapar (Wh.Pl.)
am (Lf.)
Saurabhanimba (Lf.)
itivraka (Sd.)
iva-nl (Rt.& St.)
lemtaka (Fr.)
lemtaka (St. Bk.)
lpadrikanda (Tuber)
Sphitakr (Rz.)
Spkk (Wh. Pl.)
Sruvavka (Fr.)
Sthlail (Fr.)
ukans (Rz.)
veta Vetasa (Lf.)
Takkola (Fr.)
Tinduka (Fr.)
Tryam (Rz.)
Tripak (Wh. Pl.)
Tuvaraka (Sd.)
Carthamus tinctorius L.
92
Carthamus tinctorius L.
94
Carthamus tinctorius L.
96
Acalypha fruticosa Forsk.
99
Trianthema decandra L.
101
Dracaena cinnabari Balf. f.
104
Hiptage benghalensis L.
106
Merremia tridentata (L.) Hall.f.
108
Polygonatum cirrhifolium Royle.
111
Gardenia gummifera L. f.
113
Enicostemma axillare (Lam.) A. Raynal. 115
Pinus gerardiana Wall.
118
Artocarpus heterophyllus Lamk.
120
Pavetta indica L.
122
Coleus amboinicus Lour.
124
Euphorbia nivulia Buch.- Ham.
127
Asarum europaeum L.
129
Bauhinia racemosa Lamk.
131
Plumbago indica L.
133
Tecomella undulata (Sm.) Seem.
135
Shorea robusta Gaertn.
137
Desmodium gangeticum DC.
139
Prosopis cineraria Druce
142
Murraya koenigii (L.) Spreng
145
Celosia argentea L.
148
Indigofera aspalathoides Vahl ex DC.
150
152
Cordia dichotoma Forst. f.
Cordia dichotoma Forst. f.
154
Typhonium trilobatum Schott
156
Dryopteris filix-mas (L.) Schott
158
Anisomeles malabarica (L.) R.Br. ex Sims 160
Flacourtia indica (Burm.f.) Merr.
163
Amomum subulatum Roxb.
165
Corallocarpus epigaeus Benth.ex Hook. f. 167
Salix alba L.
169
Illicium verum Hook. f.
171
Diospyros peregrina Gurke
173
Gentiana kurroo Royle
175
Coldenia procumbens L.
177
Hydnocarpus pentandra (Buch.-Ham.)
180
Oken
Glinus lotoides L.
182
Pennisetum typhoides (Burm.f.) Stapf & 185
C.E. Hubb.
Gisekia pharnaceoides L.
187
Plantago lanceolata L.
189
Calamus rotang L.
191
Pergularia daemia (Forsk)) Chiov.
193
Garcinia pedunculata Roxb.
196
Doronicum hookeri C.B.Clarke
198
Cinnamomum zeylanicum Blume
200
Gaultheria fragrantissima Wall.
202
VIII
Saccharum officinarum L.
Apis sps.
-
204
206
208
210
212
214
216
218
220
222
224
226
APPENDIX-1
1.1
APPENDIX -2
2.1 Tests and Determinations
2.1.1.
2.1.2.
2.1.3.
2.1.4.
2.1.5.
2.1.6.
2.1.7.
233
Microscopic identification
Microscopical Methods of Examining Crude Vegetable Drugs
Types of Stomata
Determination of Stomatal Index
Determination of Palisade Ratio
Determination of Vein-Islet Number
Determination of Stomatal Number
- Net Content
- Foreign Matter
- Determination of Toatal Ash
- Determination of Acid Insoluble Ash
- Determination of Water Soluble Ash
- Determination of Sulphated Ash
- Determination of Alcohol Soluble Extractive
IX
233
236
239
240
240
241
242
242
242
242
242
242
243
243
243
243
243
243
244
244
245
245
245
246
248
248
249
249
249
249
249
250
251
251
251
252
252
256
256
259
259
261
261
263
266
275
277
280
282
283
284
286
288
APPENDIX-3
3.1. Physical Tests and Determinations
3.1.1. - Refractive Index
3.1.2. - Weight per Millimetre and Specific Gravity
3.1.3. - Determination of pH Values
290
290
290
291
291
291
293
294
296
297
298
298
298
299
300
300
301
301
301
302
303
APPENDIX- 4
4.1. Reagents and Solutions
307
APPENDIX-5
5.1. Chemical Tests and Assays
336
XI
336
336
336
337
337
337
338
338
338
340
341
342
343
343
343
344
345
345
345
345
346
346
346
APPENDIX - 6
6.1. Weights and Measures
349
349
350
APPENDIX - 7
7.1. - Classical Ayurvedic References
351
INDEX
388
DEFINITIONS
415
416
418
420
423
425
XII
LEGAL NOTICES
In India there are laws dealing with drugs that are the subject of monographs which
follow. These monographs should be read subject to the restrictions imposed by these laws
wherever they are applicable.
It is expedient that enquiry be made in each case in order to ensure that the provisions
of the law are being complied with.
In general, the Drugs & Cosmetics Act, 1940 (subsequently amended in 1964 and
1982), the Dangerous Drugs Act, 1930 and the Poisons Act, 1919 and the rules framed there
under should be consulted.
Under the Drugs & Cosmetics Act, the Ayurvedic Pharmacopoeia of India (A.P.I.),
Part-I, Vol. VI, is the book of standards for single drugs included therein and the standards
prescribed in the Ayurvedic Pharmacopoeia of India, Part-I, Vol. VI, would be official. If
considered necessary these standards can be amended and the Chairman of the Ayurvedic
Pharmacopoeia Committee authorized to issue such amendments. Whenever such
amendments are issued, the Ayurvedic Pharmacopoeia of India, Part-I, Vol. VI, would be
deemed to have been amended accordingly.
XIII
GENERAL NOTICES
Title - The title of the book is Ayurvedic Pharmacopoeia of India. Wherever the
abbreviation A.P.I. is used, it may be presumed to stand for the same and the supplements
thereto.
Name of the Drugs - The name given on the top of each monograph of the drug is in
Sanskrit as mentioned in the Ayurvedic classics and/or in the Ayurvedic Formulary of India,
Part-I and Part-II will be considered official. These names have been arranged in English
alphabetical order. The Latin name (taxonomical nomenclature) of each drug as found in
authentic scientific literature has been provided in the monograph in the introductory
paragraph. The official name will be the main title of the drug and its scientific name will
also be considered as legal name.
Introductory Para - Each monograph begins with an introductory paragraph indicating the
part, scientific name of the drug in Latin with short description about its habit, distribution
and method of collection, if any.
Synonyms - Synonyms of each drug appearing in each monograph in Sanskrit, English,
Hindi, Urdu and other Indian regional languages have been mentioned as found in the
classical texts, Ayurvedic Formulary of India, Part-I and Part-II as procured from the experts,
scholars of Ayurveda and officials in the field from different states.
Italics - Italic type has been used for scientific name of the drug appearing in the
introductory paragraph of each monograph as also for chemicals and reagents, substances or
processes described in Appendix.
Odour and Taste - Wherever a specific odour has been found it has been mentioned but the
description as odourless or no odour has in many cases been avoided in the description, as
large numbers of drugs have got no specific odour. The odour is examined by directly
smelling 25 g of the powdered drug contained in a package or freshly powdered. If the odour
is discernible the sample is rapidly transferred to an open container and re-examined after 15
minutes. If the odour persists to be discernible, it is described as having odour.
The Taste of a drug is examined by taking a small quantity of 85 mesh powder by a
tip of moist glass rod and applying it on tongue previously rinsed with water. This may not
be done in case if poisonous drugs, indicated in monograph.
Mesh Number - Wherever the powdering of the drug has been required the sieve Mesh
Number 85 has been used. This will not apply for drugs containing much oily substance.
Weights and Measures - The metric system of weights and measures is employed. Weights
are given in multiples or fractions of a gramme (g) or of a milligram (mg). Fluid measures
are given in multiples or fractions of millilitre (ml).
When the term drop is used, the measurement is to be made by means of a tube,
which delivers in 20 drops 1 gram of distilled water at 15oC.
XIV
Metric measures are required by the Pharmacopoeia to be graduated at 20oC and all
measurements involved in the analytical operations of the Pharmacopoeia are intended,
unless otherwise stated to be made at that temperature.
Identity, Purity and Strength - Under the heading Identification tests are provided as an
aid to identification and are described in their respective monographs.
The term Foreign Matter is used to designate any matter, which does not form part
of the drug as defined in the monograph. Vegetable drugs used as such or in formulations,
should be duly identified and authenticated and be free from insects, pests, fungi, microorganisms, pesticides, and other animal matter including animal excreta, be within the
permitted and specified limits for lead, arsenic and heavy metals, and show no abnormal
odour, colour, sliminess, mould or other evidence of deterioration.
The quantitative tests e.g. total ash, acid-insoluble ash, water-soluble ash, alcoholsoluble extractive, water- soluble extractive, ether-soluble extractive, moisture content,
volatile oil content and assays are the methods upon which the standards of Pharmacopoeia
depend. The methods for assays are described in their respective monographs and for other
quantitative tests, methods are not repeated in the text of monographs but only the
corresponding reference of appropriate appendix is given. The analyst is not precluded from
employing an alternate method in any instance if he is satisfied that the method, which he
uses, will give the same result as the Pharmacopoeial Method. In suitable instances the
methods of microanalysis, if of equivalent accuracy, may be substituted for the tests and
assays described. However, in the event of doubt or dispute the methods of analysis of the
Pharmacopoeia are alone authoritative.
Standards - For statutory purpose, statements appearing in the API, Part-I, Vol. VI, under
Description, those of definition of the part and source plants, and Identity, Purity and
Strength, shall constitute standards.
Thin Layer Chromatography (T.L.C.) - Under this head, wherever given, the number of
spots and Rf values of the spots with their colour have been mentioned as a guide for
identification of the drug and not as Pharmacopoeial requirement. However, the analyst may
use any other solvent system and detecting reagent in any instance if he is satisfied that the
method which he uses, even by applying known reference standards, will give better result to
establish the identity of any particular chemical constituent reported to be present in the drug.
Quantities to be Weighed for Assays and Tests - In all description quantity of the
substance to be taken for testing is indicated. The amount stated is approximate but the
quantity actually used must be accurately weighed and must not deviate by more than 10 per
cent from the one stated.
Constant Weight - the term Constant Weight when it refers to drying or ignition means
that two consecutive weighings do not differ by more than 1.0 mg per g of the substance
taken for the determination, the second weighing following an additional hour of drying on
further ignition.
Constituents - Under this head only the names of important chemical constituents, groups of
constituents reported in research publications have been mentioned as a guide and not as
pharmacopoeial requirement.
XV
Percentage of Solutions - In defining standards, the expression per cent (%), is used,
according to circumstances, with one of the four meanings given below.
Per cent w/w (percentage weight in weight) expresses the number of grammes of
active substance, in 100 grammes of product.
Per cent w/v (Percentage weight in volume) expresses the number of grammes of
active substance in 100 millilitres of product.
Per cent v/v (percentage volume in volume) expresses the number of millilitres of
active substance in 100 millilitres of product.
Per cent v/w (percentage volume in weight) expresses the number of millilitres of
active substance in 100 grammes of product.
Percentage of alcohol - All statements of percentage of alcohol (C2H5OH) refer to
percentage by volume at 15.56 oC.
XVI
Descriptive terms
Very soluble
Freely soluble
Soluble
Sparingly soluble
Slightly soluble
Very slightly soluble
Practically insoluble
XVII
Kg.
g.
mg.
ml.
IN.
0.5 N
0.1 N
1M.
Fam.
PS.
TS.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Metre
Litre
Millimetre
Centimetre
Micron (0.001 mm)
Kilogram
Gramme
Milligram
Millilitre
Normal solution
Half-normal solution
Decinormal solution
Molar solution
Family
Primary Standards
Transverse Section
.
.
.
.
.
.
.
.
.
.
.
.
.
.
Sanskrit
Assamese
Bengali
English
Gujrati
Hindi
Kannada
Kashmiri
Malayalam
Marathi
Oriya
Punjabi
Tamil
Telgu
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
XVIII
PREFACE
The first and second part of the Ayurvedic Formulary of India comprising of 444 and
191 formulations respectively cover more than 351 single drugs of plant origin. This is part
of nearly 500 priority single drugs of plant origin to come with in the ambit of the Ayurvedic
Pharmacopoeia of India. The Ayurvedic Pharmacopoeia of India, Part-I, Vol-I, Vol-II, Vol
III, Vol IV and V comprises 80, 78, 100, 68 and 72 monographs of Ayurvedic single drugs of
plant origin which go into one or more formulations included in the Ayurvedic Formulary of
India, Part-I and Part-II. As a continuing activity monographs on 96 single drugs of plant
origin and four monographs each on Gua (Jaggery), Goghta (Clarified Cows Butter), Jala
(Potable water), Madhu (Honey) and arkar (Sugar) used as Vehicle or adjuvant, making
compilation of Vol VI of the Ayurvedic Pharmacopoeia of India Part-I comprising of these
101 monographs. In compiling the monograph, each monograph bears the title of the drug in
Sanskrit as given in Ayurvedic Formulary of India. This is followed by definition of the drug
giving botanical identity by using scientific binomial nomenclature with authority and very
brief information about its source, occurrence, distribution and precautions to be taken during
collection, if any. List of synonyms in Sanskrit and also in other Indian regional languages.
The monograph further records macroscopic and microscopic description of the drug
highlighting diagnostic features for identification and authentication even if the drug is in
powdered state. The monograph further gives under Identity, Purity and Strength, certain
physico chemical parameters such as limits of foreign matter, moisture content, total ash,
acid insoluble ash, alcohol soluble extractive, water soluble extractive, volatile content (if
any) followed by thin layer chromatographic fingerprint profile. Wherever feasible, an Assay
of active/marker chemical constituent or a group of chemical constituents such as total
alkaloids or volatile oil etc have been given. There is always range of variations in data on
chemical constituents and certain physico chemical parameters due to geographical, climatic
and ontogenetic variability. Therefore, variations in results of such data pose difficulty in
fixing narrow range. The data has been given on the basis of average results of 3 samples
from different laboratories. Under the constituents major chemical constituents as reported in
the literature have been given.
Under each monograph, classical attributes of each drug according to the doctrine of
Rasa, Gua, Vrya, Vipka and Karma have been kept intact. These are considered a
XIX
reasonable basis and convenient reference point for a clinical classification. Such parameters
are not possible to measures by modern scientific methods thus not mandatory.
The legal notices and general notices have been provided for pharmaceutical and
regulatory purposes. The Appendices include details of the apparatus, reagents, chemicals,
solution tests, methods of preparation of samples for microscopic or chromatographic
examination.
The committee hopes that the publication of Ayurvedic Pharmacopoeia of India, PartI Vol-VI containing 101 monographs would add to the requirements under the Drugs and
Cosmetic Act. The regular monitoring of the manufactured and marketed Ayurvedic drugs,
on the basis of the standards prescribed here in would bear evidence of the usefulness of
these volumes and help ensure their quality and status revision for the future.
The Committee urges the Government of India to recommend the adoption of these
monographs for the purposes of identity, purity and strength of drugs for use in their
Government, Semi-Government and Government aided institutions and voluntary public
organizations. The Ayurvedic Pharmacopoeia of India, Part-I, Vol. VI, 2008 would be added
to Rule 168 of the Drugs and Cosmetics Act and be notified by Government as standards to
be complied with by the manufacturers for sale or distribution of Ayurvedic drugs.
Ayurvedic Pharmacopoeia of India, Part-I, Vol. I, II, III, IV and V are already included in the
First Schedule of Drugs & Cosmetics act 1940.
Prof. S.S.Handa
Chairman
Dr. S.K.Sharma
Dr. G.S.Lavekar
Vice-Chairman
Member Secretary
XX
ACKNOWLEDGMENT
XXI
INTRODUCTION
The Ayurvedic system of medicine has been prevalent in India since the Vedic
period, and still remains the mainstay of medical relief to over 60 per cent of the population
of the nation. In earlier times the practitioners of Ayurveda (Vaidya) were themselves
collecting herbs and other ingredients and preparing medicines. For the purpose of acquiring
raw materials Vaidyas now depend on commercial organizations trading in crude herbal
drugs. Likewise, with passage of time a number of Ayurvedic Pharmaceutical units have
come up for the manufacture of Ayurvedic drugs and formulations on commercial scale.
Under the circumstances and responding to opinions of the scientific community after
independence, the Govt. of India began a series of measures to introduce a quality control
system, from 1964 onwards similar to that existing already under the Drugs and Cosmetics
Act, 1940, for western medicine. The Government of India introduced an amendment in 1964
to the Drug and Cosmetics Act 1940, to control to a limited measure the Ayurvedic, Siddha
and Unani drugs.
The Act was accordingly amended in 1964, to ensure only a limited control over the
production and sale of Ayurvedic medicines namely:i.
ii.
The raw materials used in the preparation of drugs should be genuine and
properly identified; and
iii.
The formula or the true list of all the ingredients contained in the drugs should
be displayed on the label of every container.
To start with, development of standards for the identity, purity and strength of single
drugs and those of formulations at a later stage, assumed importance for the effective
enforcement of the provision of the Act. If the raw materials to be used in a medicine and
stage-by-stage processes of manufacturers are standardised, the final product namely, the
compound formulation could be expected to conform to uniform standards. The requirement
that the list of ingredients be displayed on the label will enable analysts to verify label
claims. It will also ensure that the manufacture do not make false claim. Arrangements to
evolve and lay down physical, chemical and biological standards, wherever even necessary,
to identify the drugs and ascertain their quality and to detect adulterations are an urgent
necessity of the profession. Setting up of Drug Standardisation Units, Research Centres,
Drug Testing Institutes and Central Drug Laboratories for Ayurvedic Medicines both at
national and regional level for this purpose are therefore, essential. The several Committees
appointed by the Government of India to assess and evaluate the status and practice of
Ayurvedic Medicine have stressed the importance of preparing an Ayurvedic
Pharmacopoeia, which is precisely a book of standards.
Having regard to all these considerations, the Central Council of Ayurvedic Research
recommended the constitution of Ayurvedic Pharmacopoeia Committee consisting of experts
on Ayurveda and other sciences. The Government of India accepted the recommendations of
XXII
the Central Council of Ayurvedic Research and constituted the First Ayurvedic
Pharmacopoeia Committee, vide their letter No. 14-8/62-ISM, dated the 20th September,
1962 for a period of three years with effect from the date of its first meeting under the
Chairmanship of Col. Sir R.N. Chopra with the following member :1. Col. Sir Ram Nath Chopra, Drugs Research Laboratory, Srinagar
Chairman
Member
Member
Member
7. Dr. C.G. Pendse, Director, Indian Council of Medical Research, New Delhi
Member
Member
Member
Member
14. S.K. Borkar, Drug Controller (India), Directorate General of Health Services,
Government of India, New Delhi
Member
Member
XXIII
Member
Member
Member
Member
Member
Member Secretary
The Committee was assigned the following functions :1. To prepare an official Formulary in two parts :(a) Single drugs, of whose identity and therapeutic value there is no doubt; and
(b) Compound preparations, which are frequently used in Ayurvedic practice
throughout the country.
2. To provide standards for drug and medicines of therapeutic usefulness or
pharmaceutical necessity commonly used in Ayurvedic practice.
3. To lay down tests for identity, quality and purity.
4. To ensure as far as possible uniformity, physical properties and active constituents;
and
5. To provide all other information regarding the distinguishing characteristics,
methods of preparation, dosage, method of administration with various anupanas
or vehicles and their toxicity.
As a first step in this direction the Ayurvedic Pharmacopoeia Committee started
preparing the official Formulary of Ayurveda in two parts as mentioned under the assigned
functions of the Committee. Since the work of preparation of Ayurvedic Formulary could not
be completed after the expiry of first three years, the Government of India extended the term
of the Committee by another three years vide their notification No. F. 20-1/66-RISM, dated
14th January, 1966 and a gain for a further period of three years vide their notification No. F.
1-1/69-APC, dated 9th January, 1969.
During the years that followed, Ayurvedic Formulary, Part I and II and Ayurvedic
Pharmacopoeia of India, Part I, Volume I - V were published, the former containing the
XXIV
compound formulations from classical Ayurvedic texts prescribed in Schedule - I to the Drug
and Cosmetics Act, and the later, laying down standards for single drugs of plant origin.
Amendment to the provisions introduced in 1982 further strengthen the ASU system by
defining misbranded, adulterated and spurious drugs in the ASU system.
Subsequently under the 10th Five Year Plan a project was initiated by the Department
to develop Method of Preparation, Standard Operative Procedures, Pharmacopoeial
Standards and Shelf Life of Compound formulations of Ayurveda appearing in Ayurvedic
Formulary of India, Parts I & II.
The work of the Ayurvedic Pharmacopoeia Committee was transferred along with
some technical staff to Central Council for Research in Ayurveda and Siddha, New Delhi as
a secretariat for APC vide letter no. X-19011/6/94-APC (AYUSH),dated 29th March, 2006.
Prof. A.N. Namjoshi (1972, 1981, 1988 and 1994) and Vaidya I. Sanjeeva Rao (1998)
and Dr. P.D. Sethi (2001) were Chairmen of reconstituted Ayurvedic Pharmacopoeia
Committee during the specified periods.
The present Ayurvedic Pharmacopoeia Committee (APC) was reconstituted under the
Deptt. of AYUSH vide letter No.X-19011/6/94-APC (AYUSH) dated 9st March, 2006
consisting of following members.
Ms. Savita Satakopan, M.Sc.
(Former Drug Analyst),
Government of Gujarat,
7/4, Padmam Flats, Seventh Street,
Nanganallur, Chennai 600 061.
Chairperson
Chairman
(23rd June, 2006 to
onwards)
Vice-Chairman
OFFICIAL MEMBERS
1.
XXV
Member-Secretary
(Ex-officio)
2.
Member (Ex-officio)
3.
Managing Director,
Indian Medicines Pharmaceutical Corporation Ltd.,
Mohan, Via Ram Nagar,
Distt.- Almora, Uttranchal.
Member (Ex-officio)
4.
Member (Ex-officio)
NON-OFFICIAL MEMBERS
Phytochemistry & Chemistry Sub-Committee
1.
Chairman
2.
Member
3.
Member
Pharmacognosy Sub-Committee
1.
Chairman
2.
Member
XXVI
Member
4.
Member
Formulary Sub-Committee
(Rasa Shastra / Bhaishajya Kalpana Ayurvedic Pharmacy)
1.
Chairman
2.
Member
3.
Member
4.
Member
5.
Member
6.
Member
7.
Member
XXVII
Ayurveda Sub-Committee
(Single Drugs of Plants, Minerals, Metals, Animal origin)
1.
Chairman
2.
Member
3.
Member
4.
Member
5.
CO-OPTED MEMBERS
1.
2.
XXVIII
Member
1.
The term of the Committee shall be for a period of three years from the date of its
first meeting and the members shall hold office for that period.
2.
The Chairman of the APC shall have the powers to form sub-committees whenever
required and to co-opt experts from outside for such sub-committees.
3.
4.
(i)
(ii)
(iii)
Keeping in view the time constraint, to identify such methods, procedures and plan of
work as would enable to publish the formulary and standards of all commonly used
drugs to be brought out in a phased manner.
(iv)
(v)
(vi)
(vii)
To develop the quality standards, safety, efficacy profile of different parts of the
plants; as well as to include new plants as Ayurvedic drugs.
(viii) Any other matter relating to the quality standards, shelf life, identification, new
formulations etc.
5.
(i)
(ii)
(iii)
To prepare drafts SOP of Ayurvedic Formularies of India from the classical texts and
other authentic sources.
XXIX
2.
3.
Central Council for Research in Ayurveda and Siddha (CCRAS), New Delhi
(Dr. V.K. Lal)
4.
5.
6.
7.
8.
9.
10.
11.
XXX